Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiu Chen

Showing results (721-730 of 732) with videos related to

Pageof 74
Sort By:
Frontiers in Immunology|December 26, 2023
Simulating immunosuppressive mechanism of <i>Microplitis bicoloratus bracovirus</i> coordinately fights <i>Spodoptera frugiperda</i>Xing-Cheng Li, Yin-Chen Ma, Jin Long, et al.
The Lancet. Infectious Diseases|July 20, 2023
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyHallie Cohn, Nathaniel Bloom, Gianna Y Cai, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
Science Translational Medicine|July 6, 2018
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E Yohe, Berkley E Gryder, Jack F Shern, et al.
Iscience|April 5, 2024
Innexin hemichannel activation by <i>Microplitis bicoloratus</i> ecSOD monopolymer reduces ROSJiang-Hui Meng, Yong-Biao Huang, Jin Long, et al.
Molecular Cancer Therapeutics|November 7, 2020
Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and NeuroblastomaJoshua T Kowalczyk, Xiaolin Wan, Edjay R Hernandez, et al.
Nature|May 29, 2024
Van der Waals polarity-engineered 3D integration of 2D complementary logicYimeng Guo, Jiangxu Li, Xuepeng Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple MyelomaBeata Holkova, Adriana Zingone, Maciej Kmieciak, et al.
BMC Public Health|January 21, 2014
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trialWu Yi Liu, Da Jiang Lu, Xia Ming Du, et al.
Zhonghua Fu Chan Ke Za Zhi|March 3, 2007
[Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region]Wei Huang, Li Li, Dong-qing Yu, et al.
Pageof 74

Showing results (721-730 of 732) with videos related to

Sort By:
Pageof 74
Frontiers in Immunology|December 26, 2023
Simulating immunosuppressive mechanism of <i>Microplitis bicoloratus bracovirus</i> coordinately fights <i>Spodoptera frugiperda</i>Xing-Cheng Li, Yin-Chen Ma, Jin Long, et al.
The Lancet. Infectious Diseases|July 20, 2023
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyHallie Cohn, Nathaniel Bloom, Gianna Y Cai, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
Science Translational Medicine|July 6, 2018
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E Yohe, Berkley E Gryder, Jack F Shern, et al.
Iscience|April 5, 2024
Innexin hemichannel activation by <i>Microplitis bicoloratus</i> ecSOD monopolymer reduces ROSJiang-Hui Meng, Yong-Biao Huang, Jin Long, et al.
Molecular Cancer Therapeutics|November 7, 2020
Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and NeuroblastomaJoshua T Kowalczyk, Xiaolin Wan, Edjay R Hernandez, et al.
Nature|May 29, 2024
Van der Waals polarity-engineered 3D integration of 2D complementary logicYimeng Guo, Jiangxu Li, Xuepeng Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple MyelomaBeata Holkova, Adriana Zingone, Maciej Kmieciak, et al.
BMC Public Health|January 21, 2014
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trialWu Yi Liu, Da Jiang Lu, Xia Ming Du, et al.
Zhonghua Fu Chan Ke Za Zhi|March 3, 2007
[Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region]Wei Huang, Li Li, Dong-qing Yu, et al.
Pageof 74